A carregar...
RNA Interference for Glioblastoma therapy: Innovation ladder from the bench to clinical trials
Glioblastoma multiforme (GBM) is the most common and deadliest type of primary brain tumor with a prognosis of 14 months after diagnosis. Current treatment for GBM patients includes “total” tumor resection, temozolomide-based chemotherapy, radiotherapy or a combination of these options. Although, se...
Na minha lista:
| Publicado no: | Life Sci |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5617340/ https://ncbi.nlm.nih.gov/pubmed/28864225 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.lfs.2017.08.027 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|